Skip to main content

Table 1 Comparison of clinical indicators of 92 MN patients before and after treatment

From: High-coverage targeted lipidomics could reveal lipid alterations and evaluate therapeutic efficacy of membranous nephropathy

Indicators

Before treatment

After treatment

Z

P

Hb (g/L)

119.5 (108.0, 136.0)

121 (112.5, 134.3)

 − 0.191

0.848

Alb (g/L)

26.8 (20.6, 30.0)

28.8 (24.5, 35.5)

 − 6.404

 < 0.0001

HDL (mmol/L)

1.2 (1.0, 1.6)

1.1 (0.9, 1.3)

 − 3.558

 < 0.0001

LDL (mmol/L)

4.2 (3.2, 5.8)

3.3 (2.7, 4.2)

 − 4.723

 < 0.0001

TG (mmol/L)

2.4 (1.6, 3.4)

1.9 (1.4, 2.6)

 − 1.931

0.053

CHOL (mmol/L)

6.5 (5.3, 8.1)

5.2 (4.4, 6.1)

 − 4.925

 < 0.0001

Scr (μmol/L)

61.9 (51.9, 75.7)

65.4 (49.5, 77.1)

 − 0.526

0.599

UA (μmol/L)

372 (292.3, 416.5)

379 (306, 423)

 − 1.620

0.105

24hpro (g/24 h)

4.189 (3.5, 5.1)

3.2 (1.0, 4.3)

 − 5.998

 < 0.0001

eGFR (mL/min/1.73m2)

99.7 (87.6, 110.0)

98.2 (81.6, 108.0)

 − 0.205

0.838